These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8571998

  • 1. The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines.
    Kost ER, Herzog TJ, Adler LM, Williams S, Mutch DG.
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):145-53. PubMed ID: 8571998
    [Abstract] [Full Text] [Related]

  • 2. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER, Mutch DG, Herzog TJ.
    Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
    [Abstract] [Full Text] [Related]

  • 3. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis.
    Grell M, Scheurich P, Meager A, Pfizenmaier K.
    Lymphokine Cytokine Res; 1993 Jun; 12(3):143-8. PubMed ID: 8394147
    [Abstract] [Full Text] [Related]

  • 4. Divergent effects of taxol on tumor necrosis factor-alpha-mediated cytolysis of ovarian carcinoma cells.
    Williams S, Mutch DG, Xu L, Collins JL.
    Am J Obstet Gynecol; 1992 Dec; 167(6):1870-6. PubMed ID: 1361719
    [Abstract] [Full Text] [Related]

  • 5. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
    Powell CB, Scott JH, Collins JL.
    Gynecol Oncol; 1998 Nov; 71(2):258-65. PubMed ID: 9826469
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
    Mutch DG, Powell CB, Kao MS, Collins JL.
    Cancer Res; 1992 Feb 15; 52(4):866-72. PubMed ID: 1737348
    [Abstract] [Full Text] [Related]

  • 8. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways.
    Grell M, Zimmermann G, Hülser D, Pfizenmaier K, Scheurich P.
    J Immunol; 1994 Sep 01; 153(5):1963-72. PubMed ID: 8051401
    [Abstract] [Full Text] [Related]

  • 9. Coexpression of the human TNF receptors TR60 and TR80 in insect cells: analysis of receptor complex formation.
    Moosmayer D, Dinkel A, Gerlach E, Hessabi B, Grell M, Pfizenmaier K, Scheurich P.
    Lymphokine Cytokine Res; 1994 Oct 01; 13(5):295-301. PubMed ID: 7858062
    [Abstract] [Full Text] [Related]

  • 10. Development of resistance to tumour necrosis factor (TNF alpha) in KYM-1 cells involves both TNF receptors.
    Meager A, Sampson LE, Grell M, Scheurich P.
    Cytokine; 1993 Nov 01; 5(6):556-63. PubMed ID: 8186367
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
    Cuello M, Ettenberg SA, Clark AS, Keane MM, Posner RH, Nau MM, Dennis PA, Lipkowitz S.
    Cancer Res; 2001 Jun 15; 61(12):4892-900. PubMed ID: 11406568
    [Abstract] [Full Text] [Related]

  • 12. Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignancies.
    Mutch DG, Massad LS, Kao MS, Collins JL.
    Am J Obstet Gynecol; 1990 Dec 15; 163(6 Pt 1):1920-4. PubMed ID: 2124085
    [Abstract] [Full Text] [Related]

  • 13. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies.
    Higuchi M, Aggarwal BB.
    J Biol Chem; 1992 Oct 15; 267(29):20892-9. PubMed ID: 1328214
    [Abstract] [Full Text] [Related]

  • 14. Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cells.
    Powell CB, Horuchi T, Kao MS, Collins JL.
    Am J Obstet Gynecol; 1993 Sep 15; 169(3):661-7. PubMed ID: 8372877
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
    Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J.
    Diabetes; 1998 Apr 15; 47(4):515-22. PubMed ID: 9568681
    [Abstract] [Full Text] [Related]

  • 16. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C, Völker P, Emons G.
    Endocrinology; 2001 Jun 15; 142(6):2369-80. PubMed ID: 11356684
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC.
    Cancer Res; 1993 Apr 15; 53(8):1939-44. PubMed ID: 8385577
    [Abstract] [Full Text] [Related]

  • 18. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA, Grosen EA, Ioli GR, Van Eden ME, Brightbill HD, Gatanaga M, DiSaia PJ, Granger GA, Gatanaga T.
    Gynecol Oncol; 1994 Nov 15; 55(2):294-303. PubMed ID: 7959299
    [Abstract] [Full Text] [Related]

  • 19. Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicity.
    Fruehauf JP, Sinha BK.
    Oncol Res; 1992 Nov 15; 4(3):91-101. PubMed ID: 1319775
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM, Porter DA, Huber SC, Cowan RG.
    Endocrinology; 1998 Dec 15; 139(12):4860-9. PubMed ID: 9832422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.